Neuberg Abha Laboratory Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 01-11-2024
- Paid Up Capital ₹ 2.43 M
as on 01-11-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 9.00%
(FY 2023)
- Profit 40.83%
(FY 2023)
- Ebitda 18.75%
(FY 2023)
- Net Worth 24.82%
(FY 2023)
- Total Assets 24.03%
(FY 2023)
About Neuberg Abha Laboratory
The Corporate was formerly known as Abha Laboratory Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.43 M, as per Ministry of Corporate Affairs (MCA) records.
Gomathy Kulandaivelu, Athmanathan Ganesan, Sandip Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999GJ2020PTC113628
- Company No.
113628
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Neuberg Abha Laboratory?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Naik  | Managing Director | 22-May-2020 | Current |
| Kirit Naik | Managing Director | 22-May-2020 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gomathy Kulandaivelu | Director | 10-Dec-2020 | Current |
| Athmanathan Ganesan | Director | 10-Dec-2020 | Current |
| Sandip Shah | Director | 10-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Neuberg Abha Laboratory.
Neuberg Abha Laboratory Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9% increase. The company also saw a substantial improvement in profitability, with a 40.83% increase in profit. The company's net worth Soared by an impressive increase of 24.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuberg Abha Laboratory?
Unlock access to Neuberg Abha Laboratory's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Magnum Imaging & Diagnostics Private LimitedActive 11 years 2 monthsAthmanathan Ganesan is a mutual person
Stakeboat Ventures LlpActive 4 years 5 monthsGomathy Kulandaivelu and Athmanathan Ganesan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neuberg Abha Laboratory?
Neuberg Abha Laboratory has a workforce of 95 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuberg Abha Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuberg Abha Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
